Intelligence / Healthtech / De Novo Grants / Hjarta Care, LLC
Approvalsnovel device granted (FDA De Novo)17 Apr 2026
Hjarta Care, LLC
17 Apr 2026: Novel device granted (FDA De Novo) · XplantR Explant Tool. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 17 Apr 2026
- Device
- XplantR Explant Tool
- Specialty
- Cardiovascular
- Product Code
- SHR
- Country
- United States
- Location
- Waukesha, WI
- Submitted
- 2025-08-07
- Reference
- DEN250033
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Hjarta Care, LLC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Cardiovascular
De Novo Grants
29 SeptBridgeSource Medical Corporationnovel device granted (FDA De Novo) · SmartRead(TM) Medical Device Identifier (4100)Approvals28 JulCaristo Diagnostics, Ltd.novel device granted (FDA De Novo) · CaRi-HeartApprovals22 MayCardiosense, Inc.novel device granted (FDA De Novo) · PCWP Analysis SoftwareApprovals29 MayReflow Medical, Inc.novel device granted (FDA De Novo) · Spur Peripheral Retrievable Stent SystemApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.